Role of Single Photon Emission Computed Tomography/computed Tomography in Diagnostic Iodine-131 Scintigraphy Before Initial Radioiodine Ablation in Differentiated Thyroid Cancer

Overview

Journal Indian J Nucl Med

Specialty Nuclear Medicine

Date 2015 Jul 15

PMID 26170564

Citations 2

Authors

Kanhaiyalal Agrawal

Anish Bhattacharya

Bhagwant Rai Mittal

Affiliations

Soon will be listed here.

Abstract

Objectives: The study was performed to evaluate the incremental value of single photon emission computed tomography/computed tomography (SPECT/CT) over planar radioiodine imaging before radioiodine ablation in the staging, management and stratification of risk of recurrence (ROR) in differentiated thyroid cancer (DTC) patients.

Materials And Methods: Totally, 83 patients (21 male, 62 female) aged 17-75 (mean 39.9) years with DTC were included consecutively in this prospective study. They underwent postthyroidectomy planar and SPECT/CT scans after oral administration of 37-114 MBq iodine-131 (I-131). The scans were interpreted as positive, negative or suspicious for tracer uptake in the thyroid bed, cervical lymph nodes and sites outside the neck. In each case, the findings on planar images were recorded first, without knowledge of SPECT/CT findings. Operative and pathological findings were used for postsurgical tumor-node-metastasis staging. The tumor staging was reassessed after each of these two scans.

Results: Single photon emission computed tomography/computed tomography localized radioiodine uptake in the thyroid bed in 9/83 (10.8%) patients, neck nodes in 24/83 (28.9%) patients and distant metastases in 8/83 (9.6%) patients in addition to the planar study. Staging was changed in 8/83 (9.6%), ROR in 11/83 (13.2%) and management in 26/83 (31.3%) patients by the pretherapy SPECT/CT in comparison to planar imaging. SPECT/CT had incremental value in 32/83 patients (38.5%) over the planar scan.

Conclusion: Single photon emission computed tomography/computed tomography is feasible during a diagnostic I-131 scan with a low amount of radiotracer. It improved the interpretation of pretherapy I-131 scintigraphy and changed the staging and subsequent patient management.

Citing Articles

Added Value of Postoperative Radioiodine Scan for Staging and Risk Stratification in Papillary Thyroid Microcarcinoma.

Kaewchur T, Namwongprom S, Waisayanand N, Pongwiwattanachai W, Ekmahachai M J ASEAN Fed Endocr Soc. 2021; 36(1):64-68.

PMID: 34177090 PMC: 8214359. DOI: 10.15605/jafes.036.01.10.

Two decades of SPECT/CT - the coming of age of a technology: An updated review of literature evidence.

Israel O, Pellet O, Biassoni L, De Palma D, Estrada-Lobato E, Gnanasegaran G Eur J Nucl Med Mol Imaging. 2019; 46(10):1990-2012.

PMID: 31273437 PMC: 6667427. DOI: 10.1007/s00259-019-04404-6.

References

Wong K, Zarzhevsky N, Cahill J, Frey K, Avram A . Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma. AJR Am J Roentgenol. 2008; 191(6):1785-94. DOI: 10.2214/AJR.08.1218. View

Harris L, Yoo J, Driedger A, Fung K, Franklin J, Gray D . Accuracy of technetium-99m SPECT-CT hybrid images in predicting the precise intraoperative anatomical location of parathyroid adenomas. Head Neck. 2007; 30(4):509-17. DOI: 10.1002/hed.20727. View

Palumbo B, Sivolella S, Palumbo I, Liberati A, Palumbo R . 67Ga-SPECT/CT with a hybrid system in the clinical management of lymphoma. Eur J Nucl Med Mol Imaging. 2005; 32(9):1011-7. DOI: 10.1007/s00259-005-1788-x. View

Mitchell G, Pratt B, Vini L, McCready V, Harmer C . False positive 131I whole body scans in thyroid cancer. Br J Radiol. 2000; 73(870):627-35. DOI: 10.1259/bjr.73.870.10911786. View

Cooper D, Doherty G, Haugen B, Hauger B, Kloos R, Lee S . Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19(11):1167-214. DOI: 10.1089/thy.2009.0110. View

Kohlfuerst S, Igerc I, Lobnig M, Gallowitsch H, Gomez-Segovia I, Matschnig S . Posttherapeutic (131)I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen. Eur J Nucl Med Mol Imaging. 2009; 36(6):886-93. DOI: 10.1007/s00259-008-1044-2. View

Sherman S . Thyroid carcinoma. Lancet. 2003; 361(9356):501-11. DOI: 10.1016/s0140-6736(03)12488-9. View

Wong K, Sisson J, Koral K, Frey K, Avram A . Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT. AJR Am J Roentgenol. 2010; 195(3):730-6. DOI: 10.2214/AJR.09.3458. View

Eichhorn W, Tabler H, Lippold R, Lochmann M, Schreckenberger M, Bartenstein P . Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution. Thyroid. 2003; 13(10):949-58. DOI: 10.1089/105072503322511355. View

10.

Verburg F, de Keizer B, van Isselt J . Use of radiopharmaceuticals for diagnosis, treatment, and follow-up of differentiated thyroid carcinoma. Anticancer Agents Med Chem. 2007; 7(4):399-409. DOI: 10.2174/187152007781058578. View

11.

Lerman H, Lievshitz G, Zak O, Metser U, Schneebaum S, Even-Sapir E . Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med. 2007; 48(2):201-6. View

12.

Utsunomiya D, Shiraishi S, Imuta M, Tomiguchi S, Kawanaka K, Morishita S . Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT. Radiology. 2005; 238(1):264-71. DOI: 10.1148/radiol.2373041358. View

13.

Leitha T, Staudenherz A . Frequency of diagnostic dilemmas in 131I whole body scanning. Nuklearmedizin. 2003; 42(2):55-62. View

14.

Yamamoto Y, Nishiyama Y, Monden T, Matsumura Y, Satoh K, Ohkawa M . Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma. J Nucl Med. 2003; 44(12):1905-10. View

15.

Barwick T, Murray I, Megadmi H, Drake W, Plowman P, Akker S . Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT. Eur J Endocrinol. 2010; 162(6):1131-9. DOI: 10.1530/EJE-09-1023. View

16.

Mar M, Miller S, Edmund Kim E, Macapinlac H . Evaluation and localization of lymphatic drainage and sentinel lymph nodes in patients with head and neck melanomas by hybrid SPECT/CT lymphoscintigraphic imaging. J Nucl Med Technol. 2007; 35(1):10-6. View

17.

Sisson J, Dewaraja Y, Wizauer E, Giordano T, Avram A . Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine. Thyroid. 2009; 19(3):297-303. PMC: 2727798. DOI: 10.1089/thy.2008.0426. View

18.

Chen L, Luo Q, Shen Y, Yu Y, Yuan Z, Lu H . Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma. J Nucl Med. 2008; 49(12):1952-7. DOI: 10.2967/jnumed.108.052399. View

19.

Krausz Y, Bettman L, Guralnik L, Yosilevsky G, Keidar Z, Bar-Shalom R . Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg. 2005; 30(1):76-83. DOI: 10.1007/s00268-005-7849-2. View

20.

Jonklaas J, Sarlis N, Litofsky D, Ain K, Bigos S, Brierley J . Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid. 2007; 16(12):1229-42. DOI: 10.1089/thy.2006.16.1229. View